Skip To Content
JEWISH. INDEPENDENT. NONPROFIT.
Make a Passover gift and support Jewish journalism. DONATE NOW
The Schmooze

Julia Louis-Dreyfus Is Recovering Well After Finishing Chemo

Julia Louis-Dreyfus, the once and future duchess of Jewish diaspora culture, was seen out today for the first time since finishing her chemotherapy treatment for breast cancer. The actress was diagnosed in September, and spoke publicly and poignantly about the prevalence of breast cancer diagnoses — using it as an opportunity to highlight the need for affordable, quality insurance.

Louis-Dreyfus’ diagnosis came just days after she won her 6th consecutive Emmy for Best Actress In A Comedy for her role in “Veep;” she added two more SAG awards for “Veep” to her collection while she was convalescing, making her the most decorated performer in the award show’s history, with nine awards in total.

The beloved Louis-Dreyfus, 56, has been missed by her fans and her “Veep” co-stars, who spoke about her at the SAG Awards, as she was not able to be present. Timothy Simons, the satirical show’s Jonah Ryan, reports that Louis-Dreyfus has been “incredibly strong” throughout her treatment, and Tony Hale (Gary, or Buster Bluth, according to preference,) adds, “We miss her greatly. We wish she were here. Big time.”

But no one has supported the star more than her sons, 20-year-old Charlie, and 25-year-old Henry, who created a supportive video for their mom’s last day of chemotherapy that is, frankly, a work of art. The clip, which Louis-Dreyfus proudly posted to Instagram earlier in the month, is below. If you have any connection to either of Louis-Dreyfus’ children, particularly the one who is a legal drinker, please let him there is a Forward writer with a dowry of 250 articles about Scarlett Johansson who is more than available for marriage.

Jenny Singer is a writer for the Forward. You can reach her at [email protected] or on Twitter @jeanvaljenny

This is a moment of great uncertainty. Here’s what you can do about it.

We hope you appreciated this article. Before you go, we’d like to ask you to please support the Forward’s independent Jewish news this Passover. All donations are being matched by the Forward Board - up to $100,000.

This is a moment of great uncertainty for the news media, for the Jewish people, and for our sacred democracy. It is a time of confusion and declining trust in public institutions. An era in which we need humans to report facts, conduct investigations that hold power to account, tell stories that matter and share honest discourse on all that divides us.

With no paywall or subscriptions, the Forward is entirely supported by readers like you. Every dollar you give this Passover is invested in the future of the Forward — and telling the American Jewish story fully and fairly.

The Forward doesn’t rely on funding from institutions like governments or your local Jewish federation. There are thousands of readers like you who give us $18 or $36 or $100 each month or year.

Support our mission to tell the Jewish story fully and fairly.

Republish This Story

Please read before republishing

We’re happy to make this story available to republish for free, unless it originated with JTA, Haaretz or another publication (as indicated on the article) and as long as you follow our guidelines.
You must comply with the following:

  • Credit the Forward
  • Retain our pixel
  • Preserve our canonical link in Google search
  • Add a noindex tag in Google search

See our full guidelines for more information, and this guide for detail about canonical URLs.

To republish, copy the HTML by clicking on the yellow button to the right; it includes our tracking pixel, all paragraph styles and hyperlinks, the author byline and credit to the Forward. It does not include images; to avoid copyright violations, you must add them manually, following our guidelines. Please email us at [email protected], subject line “republish,” with any questions or to let us know what stories you’re picking up.

We don't support Internet Explorer

Please use Chrome, Safari, Firefox, or Edge to view this site.